with an actual physical measure is not surprising.
Despite this fact, UPDRS III was chosen for the
validation because it is the clinical golden standard
for diagnosis and prognosis. The correlation study
revealed that the fine movements like pinching
expresses bradykinesia well. Further testing of linear
model showed that this method is less error-prone
than the UPDRS. If a physician makes 1 scale-unit
error for each item, the error becomes
which is a value much larger than our proposed
model’s error.
5 CONCLUSION
The study proved that a commercially available
cheap Leap Motion device can be used to measure
bradykinesia level from simple motor tasks. In
comparison to UPDRS scoring relying on the
physicians’ observations, it provides repeatable and
quantitative measurements. These two major
advantages of technique make it suitable for research
purposes where the detection of subtle changes in
symptoms is required. The possibility of using a
COTS device can be an invaluable asset for other
researchers. With further investigations such as
comparison with the results of another clinical
physiologic sensor, Leap Motion can be converted to
the household self-assessment device. Unfortuna-
tely, in our study, the data exclusion rate was high,
which calls for attention to investigate further the
applicability of this procedure in the clinic.
REFERENCES
Blandini, F., Nappi, G., Tassorelli, C. and Martignoni, E.
(2000). Functional changes of the basal ganglia
circuitry in Parkinson's disease. Progress in
Neurobiology, 62(1), pp.63-88.
Calne, D., Snow, B. and Lee, C. (1992). Criteria for
diagnosing Parkinson's disease. Annals of Neurology,
32(S1), pp.S125-S127.
Daneault, J., Carignan, B., Sadikot, A. and Duval, C.
(2013). Are quantitative and clinical measures of
bradykinesia related in advanced Parkinson's disease?.
Journal of Neuroscience Methods, 219(2), pp.220-223.
Dunnewold, R., Jacobi, C. and van Hilten, J. (1997).
Quantitative assessment of bradykinesia in patients
with Parkinson's disease. Journal of Neuroscience
Methods, 74(1), pp.107-112.
Fahn, S., Marsden, C., Goldstein, M. and Calne, D.
(1987). Recent developments in Parkinson's disease.
Volume 2. Florham Park: Macmillan Healthcare
Information, pp.153–163.
Ghassemi, M., Lemieux, S., Jog, M., Edwards, R. and
Duval, C. (2006). Bradykinesia in patients with
Parkinson's disease having levodopa-induced
dyskinesias. Brain Research Bulletin, 69(5), pp. 512-
518.
Kandori, A., Yokoe, M., Sakoda, S., Abe, K., Miyashita,
T., Oe, H., Naritomi, H., Ogata, K. and Tsukada, K.
(2004). Quantitative magnetic detection of finger
movements in patients with Parkinson’s disease.
Neuroscience Research, 49(2), pp.253-260.
Marsili, L., Agostino, R., Bologna, M., Belvisi, D., Palma,
A., Fabbrini, G. and Berardelli, A. (2014).
Bradykinesia of posed smiling and voluntary
movement of the lower face in Parkinson's disease.
Parkinsonism & Related Disorders, 20(4), pp. 370-
375.
Salarian, A., Russmann, H., Wider, C., Burkhard, P.,
Vingerhoets, F. and Aminian, K. (2007).
Quantification of Tremor and Bradykinesia in
Parkinson's Disease Using a Novel Ambulatory
Monitoring System. IEEE Transactions on Biomedical
Engineering, 54(2), pp.313-322.
Sande de Souza, L., Dionísio, V. and Almeida, G. (2011).
Multi-joint movements with reversal in Parkinson’s
disease: Kinematics and electromyography. Journal of
Electromyography and Kinesiology, 21(2), pp.376-
383.
Weichert, F., Bachmann, D., Rudak, B. and Fisseler, D.
(2013). Analysis of the Accuracy and Robustness of
the Leap Motion Controller. Sensors, 13(5), pp.6380-
6393.
BIOSIGNALS 2018 - 11th International Conference on Bio-inspired Systems and Signal Processing
232